Bank of New York Mellon Corp vs Twist Bioscience Corp — how do they compare? Bank of New York Mellon Corp trades at $160.21 (market cap $108.78B), while Twist Bioscience Corp trades at $125.49 (market cap $7.72B). The key difference: Bank of New York Mellon Corp is far larger — about 14.1× Twist Bioscience Corp's market cap, and Bank of New York Mellon Corp pays a 1.38% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| BNY | TWST | |
|---|---|---|
Market Cap | $108.78B | $7.72B |
Sector | Financials | Health |
52-Week High | $162.35 | $124.88 |
52-Week Low | $101.00 | $24.16 |
Dividend Yield | 1.38% | — |
Enterprise Value | — | $7.65B |
Signals from Pluang's Aura AI — not financial advice
BNY stock trades at $159.44, up 1.14% on the day, near the analyst consensus price target of $170.36. The stock shows a bullish technical trend with strong moving average signals, and fundamentals are robust with consistent earnings beats, revenue growth to $19.76B in 2025, and a net income margin of 29.96%. Recent news highlights strategic moves in digital asset infrastructure and a dividend declaration.
The outlook for BNY is positive, supported by earnings momentum and digital innovation, but risks include high investing cash outflows and interest expenses. Analyst sentiment is mixed with a slight hold bias, yet institutional upgrades and a strong ROE of 15.34% offer upside potential amid market volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
BNY Mellon is a global investment company involved in managing and servicing financial assets throughout the investment lifecycle. The bank provides financial services for institutions, corporations, and individual investors and delivers investment management and investment services in 35 countries and more than 100 markets. BNY Mellon is the largest global custody bank in the world, with about $41.1 trillion in under custody and administration (as of Dec. 31, 2020), and can act as a single point of contact for clients looking to create, trade, hold, manage, service, distribute, or restructure investments. BNY Mellon's asset-management division manages about $2.2 trillion in assets.
Read more on BNY →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →